AURORA SPINE RECEIVES HEALTH CANADA MEDICAL DEVICE LICENSE FOR ZIP™ MIS INTERSPINOUS FUSION SYSTEM
Aurora Spine Corporation (TSXV:ASG) announced today that it has received the Health Canada Medical Device License for its ZIP™ Interspinous Fusion System. Aurora Spine's ZIP MIS Interspinous fixation implant for spinal fusion, consists of a ONE-STEP™ locking mechanism, articulating spikes and various sizes to accommodate variations in patient anatomy which eliminates the use of a set screw.
The ZIP MIS Interspinous Fusion System is a key product in Aurora Spine's Screwless Procedure™, a cutting-edge surgical approach to spine fusion. The Screwless Procedure has been developed to increase the possibility of significant benefits to patients, hospitals, and surgeons, including reduced surgery time, shorter hospital stays, and significantly faster recovery time. These benefits will continue to be the driving force of Aurora Spine's competitive advantage and growth.
"Aurora is changing spine surgery and we are excited to receive the Health Canada Medical Device License for our ZIP MIS Interspinous Fusion System," said Trent J. Northcutt, President and CEO of Aurora Spine. "As a company traded on the TSX Venture Exchange, this is a significant milestone for Aurora Spine and its global growth. We are pleased to offer the ZIP MIS Interspinous Fusion System in Canada and introduce Aurora Spine's advanced, innovative, minimally invasive spine surgery technologies which are designed to improve spine patient outcomes, drive continued surgeon interests and provide unique benefits that deliver value to hospitals and patients."
Aurora Spine received U.S. FDA clearance on the ZIP MIS Interspinous Fusion System in November 2013 and already has its CE mark and Australian TGA listing for the product.
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine recently obtained its 5th FDA clearance in the past 11 months and continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company's commitment to - Simplifying the Complex.
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company's products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Aurora Spine Corporation
President and Chief Executive Officer
Chief Financial Officer